The Enterprise Value as of December 2024 (TTM) for United Therapeutics Corporation (UTHR) is 15.08B

According to United Therapeutics Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 15.08B. This represents a change of 25.57% compared to the average of 12.01B of the last 4 quarters.

United Therapeutics Corporation (UTHR) Historical Enterprise Value (quarterly & annually)

How has UTHR Enterprise Value performed in the past?

The mean historical Enterprise Value of United Therapeutics Corporation over the last ten years is 7.06B. The current 15.08B Enterprise Value has changed 21.26% with respect to the historical average. Over the past ten years (40 quarters), UTHR's Enterprise Value was at its highest in in the September 2024 quarter at 14.83B. The Enterprise Value was at its lowest in in the June 2019 quarter at 3.76B.

United Therapeutics Corporation (UTHR) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of United Therapeutics Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

United Therapeutics Corporation (UTHR) Average Enterprise Value

How has UTHR Enterprise Value performed in the past?

The current Enterprise Value of United Therapeutics Corporation (UTHR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

United Therapeutics Corporation (UTHR) Enterprise Value vs. Peers

How is UTHR’s Enterprise Value compared to its peers?

United Therapeutics Corporation’s Enterprise Value is greater than Incyte Corporation (12.19B), less than Alnylam Pharmaceuticals, Inc. (31.45B), greater than Ultragenyx Pharmaceutical Inc. (3.93B), greater than Apellis Pharmaceuticals, Inc. (4.20B), greater than Replimune Group, Inc. (892.33M), greater than Nuvalent, Inc. (5.59B), greater than Ventyx Biosciences, Inc. (115.44M), greater than Ascendis Pharma A/S (8.19B), greater than MannKind Corporation (2.11B), greater than Larimar Therapeutics, Inc. (222.97M), greater than Day One Biopharmaceuticals, Inc. (859.59M), greater than Kiniksa Pharmaceuticals, Ltd. (1.38B), less than BeiGene, Ltd. (18.02B), greater than Akero Therapeutics, Inc. (1.70B), greater than Blueprint Medicines Corporation (6.12B), greater than Vaxcyte, Inc. (9.83B), greater than Legend Biotech Corporation (6.11B),

Build a custom stock screener for United Therapeutics Corporation (UTHR) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like United Therapeutics Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

United Therapeutics Corporation (UTHR) and other stocks custom spreadsheet templates

The easiest way to analyze a company like United Therapeutics Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.